“A lot of the participants in our trials have tried one or more different types of either behavioral treatments or pharmacological treatments,” Christopher Nicholas said. “They’re looking for another option.”
He’s optimistic psychedelics paired with therapy will give patients a new tool. He worked on a 2023 study that found participants’ depression scores improved about six weeks after a single dose of psilocybin.